Tuesday, 10 March 2026
PERSPECTA
News from every angle
All
World
Politics
Business
Technology
Finance
Science
Health
Sport
Culture
Opinion
Environment
← Back to headlines
Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny
4 Mar, 07:30 — 4 Mar, 07:30
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
Yahoo
Mostly Factual
5d ago
Canaccord Lowers Hims & Hers Health, Inc. (HIMS) Price Target Patent Amid Dispute and FDA Scrutiny
Read full article →
Something wrong with this story? Report an issue
Related Stories
High HPV awareness, but barriers stall PH vaccination
just now
Baguio Health Office expands services to include eye test
just now
Eine Kappe, die Ohren und Nacken schützt
15m ago
Συνθετικά της κάνναβης μπορούν να αντιστρέψουν νόσο που πλήττει το ένα τρίτο των ενηλίκων
17m ago
Tuesday, 10 March 2026
Explore
Log in
Sign up
PERSPECTA
News from every angle
